Showing results (61-70 of 120) with videos related to
Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2011
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancerN Katsumata, Y Hirai, S Kamiura, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2010
Compliance with Good Clinical Practice in oncology registration trials in JapanK Yonemori, A Hirakawa, M Ando, et al.Endocrine Journal|October 28, 1998
G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasiaN Katsumata, T Kuno, S Miyazaki, et al.Human Mutation|April 24, 1999
A novel frameshift mutation 840delA and a novel polymorphism D203A in the steroidogenic acute regulatory protein gene in a Japanese patient with congenital lipoid adrenal hyperplasia. Mutations in brief no. 117. OnlineN Katsumata, A Tanae, T Shinagawa, et al.International Journal of Cancer|March 10, 2001
Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapyS Akashi-Tanaka, T Fukutomi, T Watanabe, et al.Hormone Research|September 11, 2001
New compound heterozygous mutation in the CYP17 gene in a 46,XY girl with 17 alpha-hydroxylase/17,20-lyase deficiencyN Katsumata, M Satoh, A Mikami, et al.Breast Cancer (Tokyo, Japan)|October 23, 2001
Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicinT Takahashi, S Akashi-Tanaka, T Fukutomi, et al.Endocrine Journal|July 13, 2000
Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasiaN Katsumata, S Mikami, A Nagashima-Miyokawa, et al.Endocrine Journal|June 1, 1997
Homozygous Q258X mutation in the steroidogenic acute regulatory gene in a Japanese patient with congenital lipoid adrenal hyperplasiaN Katsumata, A Tanae, T Shinagawa, et al.Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogueT Tanaka, M Satoh, T Yasunaga, et al.Pageof 12